Aromatase Inhibitors in Premenopausal Women: The Need for Proper Contraceptive Counseling

Ingrid Vandenput, Ignace Vergote, Frédéric Amant, Patrick Neven, Robert Paridaens, Marie-Rose Christiaens
In: The Breast Journal · 2006 · vol. 12(5) , pp. 507–508 · doi:10.1111/j.1075-122x.2006.00318.x · PMID:16958981 · W2074972709
letter OA: closed CC0 ⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper addresses the critical need for thorough contraceptive counseling for premenopausal women prescribed aromatase inhibitors due to their potential teratogenicity and high risk of ovulation induction.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

References (5)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK